Aqueous humor levels of topically applied levofloxacin in human eyes

Current Eye Research

Volumn 24, Issue 5, 2002, Pages 403-406

  Yamada, Masakazu ^a   Mochizuki, Hiroshi ^a,b   Yamada, Kyoko ^a,b   Kawai, Masataka ^a   Mashima, Yukihiko ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sano Kosei General Hospital   (Japan)

Author keywords

Aqueous humor; Cornea; Fluoroquinolones; High performance liquid chromatography; Levofloxacin

Indexed keywords

LEVOFLOXACIN;

AGED; AQUEOUS HUMOR; ARTICLE; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; ENDOPHTHALMITIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0036936998     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.24.5.403.8517     Document Type: Article

References (17)

1. Ogawa GS, Hyndiuk RA. The fluoroquinolones: New antibiotics in ophthalmology. Int Ophthalmol Clin. 1993;33:59-68.
2. Ernst ME, Ernst EJ, Klepser ME. Levofloxacin and trovafloxacin: The next generation of fluoroquinolones? Am J Health-Syst Pharm. 1997;54:2569-2584.
3. Wimer SM, Schoonover L, Garrison MW. Levofloxacin: A therapeutic review. Clin Ther. 1998;20:1049-1070.
4. Graves A, Henry M, O'Brien TP, Hwang DG, Van Buskirk A, Trousdale MD. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea. 2001;20:301-305.
5. Usui M. Clinical evaluation of levofloxacin ophthalmic solution: A multicenter phase III double-masked clinical trial. Atarasii Ganka (in Japanese). 1997;14:641-648.
6. Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharma. 1990;63:237-250.
7. Kawashima Y, Takashina H, Usui M. Pharmacokinetic parameters of ofloxacin and levofloxacin ophthalmic solutions. Atarasii Ganka (in Japanese). 1995;12:791-794.
8. Fiscella RG, Nguyen TK, Cwik MJ, Phillpotts BA, Friedlander SM, Alter DC, Shapiro MJ, Blair NP, Gieser JP. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology. 1999;106:2286-2290.
9. Beck R, Van Keyserlingk J, Fischer U, Guthoff R, Drewelow B. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different application modes. Graefe's Arch Clin Exp Ophthalmol. 1999;237:89-92.
10. Cekic O, Batman C, Totan Y, Yasar U, Basci NE, Bozkurt A, Kayaalp SO, Zilelioglu O. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects. Eye. 1999;13:656-659.
11. Hanioglu-Kargi S, Basci N, Soysal H, Bozkurt A, Gursel E, Kayaalp O. The penetration of ofloxacin into human aqueous humor given by various routes. Eur J Ophthalmol. 1998;8:33-36.
12. Donnenfeld ED, Perry HD, Snyder RW, Moadel R, Elsky M, Jones H. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch Ophthalmol. 1997;115:173-176.
13. McDermott ML, Tran TD, Cowden JW, Buggé CJL. Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmology. 1993;100:197-200.
14. Price FW, Whitson WE, Gonzales J, Johns S. Corneal tissue levels of topically applied ofloxacin. J Cataract Refract Surg. 1997;23:898-902.
15. Diamond JP, White L, Leeming JP, Hoh HB, Easty DL. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: A new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol. 1995;79:606-609.
16. Blondeau JM. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones. J Antimicrob Chemother. 1999;43(Suppl B):1-11.
17. Kowalski RP, Pandya AN, Karenchak LM, Romanowski EG, Husted RC, Ritterband DC, Shah MK, Gordon YJ. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology. 2001;108:1826-1829.